Stock Quote
Bristol-Myers Squibb Company (BMY.N) (New York Stock Exchange)
$24.46
20 Nov 2009
+1.79%
$24.03
$23.89
7,362,500
$24.49
$23.89
$24.63
$17.23
0.71
15,816,203
BMY.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Cornelius, James | Chairman of the Board, Chief Executive Officer | 25,037,768 |
| Andreotti, Lamberto | President, Chief Operating Officer, Director | 10,755,297 |
| Huet, Jean-Marc | Chief Financial Officer, Executive Vice President | 3,944,556 |
Profile
Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products. The Company had two segments: Pharmaceuticals and Nutritionals. The Pharmaceuticals segment is made up of the global... Full Description
Company Address
Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
P: +1212.5464000
F: +1212.5464020
345 Park Avenue
New York NY 10154
P: +1212.5464000
F: +1212.5464020
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Johnson & Johnson | $62.31 | +0.37 |
| Pfizer Inc. | $18.36 | +0.25 |
| GlaxoSmithKline plc | £1,253.50 | +13.00 |
| BMY.N | Industry | |
|---|---|---|
| P/E(TTM) | 12.86 | 6.90 |
| P/S(TTM) | 2.29 | 1.54 |
| ROI(TTM) | 21.99 | 6.18 |
| ROE(TTM) | 27.47 | 9.32 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | 0.53 |
| EPS Est. (Current Year) | 2.02 |
| Total Revenue | $5,487.00M |
| Net Income | $1,290.00M |
| EPS | $0.48 |
